SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing significant retail momentum as traders flock to the stock on rumors of a potential short squeeze, citing high short interest and speculative talk of a private buyout. Community members are actively sharing their positions and debating the brand's long-term value, creating a volatile environment driven by intense retail interest and discussions about leadership changes.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is facing significant selling pressure and heightened volatility as investors weigh a strong revenue beat against a concerning outlook for declining gross margins in the coming quarters. Community discussion is sharply divided between those viewing the pullback as a buying opportunity given the company's high-profile OpenAI contract and those skeptical of its long-term valuation relative to chip-sector giants.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is drawing significant investor interest as the community rallies around its pivot to AI-focused data center infrastructure and anticipated capacity growth. Bullish sentiment is being driven by upcoming Russell index inclusion, potential hyperscaler lease announcements, and a perceived scarcity of high-quality power assets for AI workloads.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant downward pressure as market sentiment shifts and high-growth AI stocks face broad technical decompression. While the community remains divided between those viewing the recent price action as a temporary liquidity reset and others bracing for deeper retracement, investor focus remains firmly anchored on whether recent enterprise contract wins can effectively decouple the stock's fundamental growth narrative from current negative price momentum.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending following a massive $700 million upsized public offering, which has sparked intense community debate over the impact of significant share dilution versus the company's strong institutional backing. While some investors interpret the upsized offering as a sign of confidence from large players in the company's upcoming clinical milestones, others are aggressively criticizing the move as a profit-taking exercise that leaves retail shareholders holding the bag.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is trending as investors react to the company's fiscal third-quarter earnings beat and raised full-year guidance, which signaled resilience and effective cost-cutting despite geopolitical and inflationary pressures. The community is actively debating the stock's valuation as it nears record highs, with many focused on the upcoming Freight division spin-off as a key catalyst for long-term value creation.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing strong momentum as anticipation builds for the Grand Theft Auto VI release, with recent market movement driven by reports of pre-order windows opening ahead of the upcoming earnings call. The community is heavily focused on the game's potential to drive historic sales, viewing the stock as a key long-term play despite broader market volatility.

Maase, Inc. engages in providing and operating integrated artificial intelligence (AI) digital systems. It focuses on flexible energy deployment and intelligent commercial network operation and offers closed-loop solutions from computing infrastructure, smart hardware, and full-scene services. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is experiencing significant volatility and community debate as investors focus on its pivot toward AI infrastructure, specifically its Huazhi Future acquisition and the development of 800VDC energy solutions for data centers. While some traders view the recent price action as a speculative momentum play driven by low float and institutional positioning, others are closely watching whether management can translate these strategic milestones into repeatable commercial revenue.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending as investors react to the company's recent pricing of an 80 million dollar public offering of common stock and pre-funded warrants. The community is heavily debating the necessity of this dilution, with many retail shareholders expressing deep frustration over leadership's performance and the threat of further share dilution.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending as investors react to a major business reset involving a massive restructuring charge and a suspended dividend, while the community intensely debates the long-term viability of its turnaround strategy focused on traditional and hybrid lineups. Market participants are split between viewing the stock as an oversold value play with deep assets and worrying about severe operational execution risks amidst an increasingly competitive global automotive landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bitcoin Rises Toward $80,000 After Oil Drops On Iran Peace Signals – Triggers $200 Million Short Squeeze

Cryptocurrency

Bitcoin’s price rose to an intraday high of nearly $80,000 as oil prices eased after reports of a potential Iran-U.S. peace deal.


Why Is SHPH Stock Soaring Today? Dogecoin Mining Pivot Sparks Rally 

Equity

Shuttle Pharmaceutical Holdings signed a definitive merger agreement to acquire United Dogecoin and become a Dogecoin miner.

5 Biotech Stocks with Highly Anticipated Pending Results

Others

Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.

Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations

George Scorsis takes helm as Chairman as Ropidoxuridine trial nears 50% enrollment and patent advances boost pipeline.

Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead

According to Goldman Sachs Research, a 5% increase in the tariff rate is estimated to reduce S&P 500 earnings per share by 1%-2%

Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe

Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News

Shares of Shuttle Pharmaceuticals are on the rise following a string of recent developments, including positive updates on its Phase 2 clinical trial, a new $4.5 million public offering and the paying off of a convertible note.

Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.

Shuttle Pharmaceuticals Holdings Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.84
Prev Close	$3.52
Open	$3.45
Dividend Yield	0.00%
50-Day Moving Average	$6.73
Beta	0.34
Avg. Volume	192,939.77
PE Ratio	-0.06

52-Week High	$55.90
52-Week Low	$3.16
Market Capitalization	$2.24M
EPS (Annual)	-$71.56
Price to Book	0.64
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SHPHShuttle Pharmaceuticals Holdings Inc

Latest SHPH News